3Y and 5Y returns are annualised.
Estimate only. It assumes the selected past return repeats every year; 3Y and 5Y figures are taken as annualised. Actual returns vary and are not guaranteed.
| # | Holding | Sector | Country | Weight | YTD |
|---|---|---|---|---|---|
| 1 | HFCL
INE548A01028 |
Technology Communication Equipment |
India |
9.55%
|
+194.48% |
| 2 | Zydus Wellness
INE768C01028 |
Consumer Defensive Packaged Foods |
India |
8.74%
|
+11.01% |
| 3 | Aster DM Healthcare
INE914M01019 |
Healthcare Medical Care Facilities |
India |
8.73%
|
+28.31% |
| 4 | Anthem Biosciences
INE0CZ201020 |
Healthcare Biotechnology |
India |
8.66%
|
+22.50% |
| 5 | SMS Pharmaceuticals
INE812G01025 |
Healthcare Drug Manufacturers - General |
India |
7.66%
|
+20.54% |
| 6 | Alivus Life Sciences
INE03Q201024 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
6.98%
|
+15.64% |
| 7 | Pfizer
INE182A01018 |
Healthcare Drug Manufacturers - General |
India |
5.92%
|
-8.99% |
| 8 | Aurobindo Pharma
INE406A01037 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
4.95%
|
+22.04% |
| 9 | HDFC Life Insurance
INE795G01014 |
Financial Services Insurance - Life |
India |
3.73%
|
-21.14% |
| 10 | Strides Pharma Science
INE939A01011 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
2.63%
|
+23.37% |
The primary investment objective of the scheme is to provide capital appreciation by investing in equity and equity related instruments including derivatives and debt and money market instruments. However, there can be no assurance that the investment objective of the Scheme will be realized, as actual market movements may be at variance with anticipated trends.
Fund manager(s): Sanjeev Sharma, Ankit A. Pande, Sandeep Tandon, Varun Pattani, Sameer Kate, Ayusha Kumbhat, Yug Tibrewal
Exit load: Exit load of 1%, if redeemed within 15 days.